We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
NEW YORK DAWN™NEW YORK DAWN™NEW YORK DAWN™
Notification Show More
Font ResizerAa
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Reading: Research succeeds in early prognosis of leptomeningeal illness in diffuse midline gliomas by liquid biopsy
Share
Font ResizerAa
NEW YORK DAWN™NEW YORK DAWN™
Search
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Follow US
NEW YORK DAWN™ > Blog > Health > Research succeeds in early prognosis of leptomeningeal illness in diffuse midline gliomas by liquid biopsy
Research succeeds in early prognosis of leptomeningeal illness in diffuse midline gliomas by liquid biopsy
Health

Research succeeds in early prognosis of leptomeningeal illness in diffuse midline gliomas by liquid biopsy

Last updated: January 28, 2025 1:19 pm
Editorial Board Published January 28, 2025
Share
SHARE

A photograph of Natsumeda lab members, together with Dr. Satoshi Shibuma (far left) and Dr. Manabu Natsumeda (far proper). Credit score: Niigata College

A bunch led by the Division of Neurosurgery, Mind Analysis Institute, Niigata College, has succeeded within the prognosis of leptomeningeal illness in diffuse midline gliomas by detecting H3K27M-mutant droplets from circulating tumor DNA of cerebrospinal fluid taken from these sufferers.

The work is printed within the journal Pediatric Blood & Most cancers on January 9, 2025.

In two sufferers, leptomeningeal illness was identified sooner than with conventional strategies reminiscent of MRI and cerebrospinal fluid cytology. In a single affected person, long run survival after the prognosis of leptomeningeal illness by early and aggressive intervention together with surgical procedure, radiation, and intrathecal supply of chemotherapeutic brokers led to long run survival.

A group led by Dr. Manabu Natsumeda used droplet digital PCR, a extremely delicate PCR system, to detect hint quantities of circulating tumor DNA from the cerebrospinal fluid of those sufferers.

“We found that detecting circulating tumor DNA in the cerebrospinal fluid of diffuse midline glioma patients was more difficult than other brain tumor patients such as primary central nervous system lymphoma and glioblastoma,” explains Dr. Natsumeda.

“However, when we were able to detect mutant tumor DNA, often the tumor had already spread to the cerebrospinal fluid, causing leptomeningeal disease. We think that early diagnosis and treatment of leptomeningeal disease in diffuse midline gliomas can improve survival.”

Extra info:
Satoshi Shibuma et al, Analysis of Leptomeningeal Illness in Diffuse Midline Gliomas by Detection of H3F3A K27M Mutation in Circulating Tumor DNA of Cerebrospinal Fluid, Pediatric Blood & Most cancers (2025). DOI: 10.1002/pbc.31535

Offered by
Niigata College

Quotation:
Research succeeds in early prognosis of leptomeningeal illness in diffuse midline gliomas by liquid biopsy (2025, January 27)
retrieved 28 January 2025
from https://medicalxpress.com/information/2025-01-succeeds-early-diagnosis-leptomeningeal-disease.html

This doc is topic to copyright. Aside from any honest dealing for the aim of personal research or analysis, no
half could also be reproduced with out the written permission. The content material is supplied for info functions solely.

You Might Also Like

Kids sweat at similar charge as adults in excessive warmth, examine finds

New analysis uncovers hyperlink between most cancers pathway and blood-retina barrier perform

Researchers discover genetic clues to toddler method pathogen’s world persistence

Wristband sensor offers all-in-one monitoring for diabetes and cardiovascular care

Coronary heart assault signs are complicated and delicate, not dramatic like motion pictures present, in accordance with research

TAGGED:biopsydiagnosisdiffusediseaseEarlygliomasleptomeningealLiquidmidlinestudysucceeds
Share This Article
Facebook Twitter Email Print

Follow US

Find US on Social Medias
FacebookLike
TwitterFollow
YoutubeSubscribe
TelegramFollow
Popular News
International Travel During Covid: The Documents You Need
Lifestyle

International Travel During Covid: The Documents You Need

Editorial Board December 10, 2021
Nate Jackson made his title on viral crowd work, however his comedy is constructed on rather more than that
WHO chief urges pandemic accord motion after US withdrawal
Stefan Noesen’s OT objective lifts Devils previous Lightning
The Tech Gifts That Are Hard to Buy This Holiday Season

You Might Also Like

Life expectancy in California has not recovered from COVID drop
Health

Life expectancy in California has not recovered from COVID drop

July 10, 2025
Clear data-sharing is a strong sign of research high quality in being pregnant analysis
Health

Clear data-sharing is a strong sign of research high quality in being pregnant analysis

July 10, 2025
Can oranges, garlic and echinacea actually assist keep away from the chilly and flu?
Health

Can oranges, garlic and echinacea actually assist keep away from the chilly and flu?

July 10, 2025
Office psychological well being in danger as key federal company faces cuts
Health

Office psychological well being in danger as key federal company faces cuts

July 10, 2025

Categories

  • Health
  • Sports
  • Politics
  • Entertainment
  • Technology
  • World
  • Art

About US

New York Dawn is a proud and integral publication of the Enspirers News Group, embodying the values of journalistic integrity and excellence.
Company
  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement
Contact Us
  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability
Term of Use
  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© 2024 New York Dawn. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?